Eligibility analysis needs the applicable program policy, the patient and encounter context, the drug movement, and retained records behind each determination.
Knowledge collection
340B
Eligibility determination, inventory accumulation, diversion controls, and the records that support each decision.
EligibilityAccumulationsDiversionAudit support
Articles
Physical and virtual inventory approaches both demand disciplined records, because the control objective is traceable, policy-consistent accountability either way.
Preventing diversion takes defined eligibility rules, attributable records, exception review, and remediation, working ahead of the transaction rather than after it.
The 340B Drug Pricing Program lets eligible covered entities buy certain outpatient drugs at reduced prices, under program requirements.
Diversion prevention is the work of keeping 340B drugs to the circumstances the program and the covered entity’s policy allow.
Related collections
How to
Step by step guides for the work people actually do in Attergo, written from journeys that were run rather than from what the screens appear to offer.
Revenue integrity
How to measure the gap between what a claim should have paid and what it did, explain the gap, and recover it.
Pharmacy economics
What a pharmacy pays for medication, what it collects for dispensing it, and how long the money sits in between.